The present invention provides 5'-modified bicyclic nucleoside analogs and oligomeric compounds comprising at least one of these nucleoside analogs. In preferred embodiments the nucleoside analogs have either (R) or (S)-chirality at the 5'-carbon. These bicyclic nucleoside analogs are useful for enhancing properties of oligomeric compounds including for example enhanced nuclease resistance.
Claims What is claimed is: 1. An oligomeric compound having the formula: G-[T-L].sub.j-[R-L].sub.q-R-[L-T].sub.r-E wherein: each T is a monomer of formula II: ##STR00032## wherein independently for each monomer having formula II: Bx is a heterocyclic base moiety; Z is C.sub.1-C.sub.6 alkyl, C.sub.2-C.sub.6 alkenyl, C.sub.2-C.sub.6 alkynyl, substituted C.sub.1-C.sub.6 alkyl, substituted C.sub.2-C.sub.6 alkenyl, substituted C.sub.2-C.sub.6 alkynyl or substituted acyl; each R is a .beta.-D-2'-deoxyribonucleoside; each L is an internucleoside linking group; G and E are each, independently, H, a hydroxyl protecting group or a linked conjugate group; wherein each substituted group is mono or poly substituted with substituent groups independently selected from halogen, C.sub.1-C.sub.6 alkyl, substituted C.sub.1-C.sub.6 alkyl, C.sub.2-C.sub.6 alkenyl, substituted C.sub.2-C.sub.6 alkenyl, C.sub.2-C.sub.6 alkynyl, substituted C.sub.2-C.sub.6 alkynyl, OJ.sub.1, SJ.sub.1, NJ.sub.1J.sub.2, N.sub.3, COOJ.sub.1, CN, O--C(.dbd.O)--NJ.sub.1J.sub.2, N(H)C(.dbd.NH)NR.sub.1R.sub.2 or N(H)C(.dbd.X)N(H)J.sub.2 wherein X is O or S; each J.sub.1 and J.sub.2 is, independently, H, C.sub.1-C.sub.6 alkyl, substituted C.sub.1-C.sub.6 alkyl, C.sub.2-C.sub.6 alkenyl, substituted C.sub.2-C.sub.6 alkenyl, C.sub.2-C.sub.6 alkynyl, substituted C.sub.2-C.sub.6 alkynyl, C.sub.1-C.sub.6 aminoalkyl, substituted C.sub.1-C.sub.6 aminoalkyl or a protecting group; q is from 7 to about 15; j is 0 or from 1 to about 5; r is 0 or from 1 to about 5; the sum of j and r is at least 1; and the sum of j, q and r is from 7 to 39. 2. The oligomeric compound of claim 1 wherein each Z is a substituted C.sub.1-C.sub.6 alkyl. 3. The oligomeric compound of claim 2 wherein each Z is substituted methyl. 4. The compound of claim 3 wherein each of said substituent groups is, independently, F, NJ.sub.1J.sub.2, N.sub.3, CN, OJ.sub.1, SJ.sub.1, O--C(.dbd.O)NJ.sub.1J.sub.2, N(H)C(.dbd.NH)NJ.sub.1J.sub.2 or N(H)C(.dbd.O)N(H)J.sub.2. 5. The oligomeric compound of claim 4 wherein each J.sub.1 and J.sub.2 is, independently H or C.sub.1-C.sub.6 alkyl. 6. The oligomeric compound of claim 1 wherein each Z is methyl, ethyl or methoxymethyl. 7. The oligomeric compound of claim 6 wherein each Z is methyl. 8. The oligomeric compound of claim 1 wherein each Z is vinyl. 9. The oligomeric compound of claim 1 wherein each Z is substituted acyl. 10. The oligomeric compound of claim 9 wherein each Z is C(.dbd.O)NJ.sub.1J.sub.2. 11. The oligomeric compound of claim 1 wherein each monomer having formula II has the configuration: ##STR00033## 12. The oligomeric compound of claim 1 wherein each monomer having formula II has the configuration: ##STR00034## 13. The oligomeric compound of claim 1 wherein each internucleoside linking group is, independently, a phosphodiester or phosphorothioate internucleoside linking group. 14. The oligomeric compound of claim 1 wherein each internucleoside linking group is a phosphorothioate internucleoside linking group. 15. The oligomeric compound of claim 1 wherein j is 0. 16. The oligomeric compound of claim 1 wherein r is 0. 17. The oligomeric compound of claim 1 wherein j and r are each other than 0. 18. The oligomeric compound of claim 1 wherein j and r are each 2. 19. The oligomeric compound of claim 18 wherein q is from about 9 to about 13. 20. The oligomeric compound of claim 1 wherein j and r are each 5. 21. The oligomeric compound of claim 20 wherein q is about 10. 22. An oligomeric compound comprising at least one monomer having formula I: ##STR00035## wherein independently for each monomer having formula I: Bx is a heterocyclic base moiety; one of T.sub.3 and T.sub.4 is an internucleoside linking group attaching the monomer having formula I to the oligomeric compound and the other of T.sub.3 and T.sub.4 is H, a hydroxyl protecting group, a linked conjugate group or an internucleoside linking group attaching the monomer having formula I to the oligomeric compound; Z is C.sub.1-C.sub.6 alkyl, C.sub.2-C.sub.6 alkenyl, C.sub.2-C.sub.6 alkynyl, substituted C.sub.1-C.sub.6 alkyl, substituted C.sub.2-C.sub.6 alkenyl, substituted C.sub.2-C.sub.6 alkynyl or substituted acyl; wherein each substituted group is mono or poly substituted with substituent groups independently selected from halogen, C.sub.1-C.sub.6 alkyl, substituted C.sub.1-C.sub.6 alkyl, C.sub.2-C.sub.6 alkenyl, substituted C.sub.2-C.sub.6 alkenyl, C.sub.2-C.sub.6 alkynyl, substituted C.sub.2-C.sub.6 alkynyl, OJ.sub.1, SJ.sub.1, NJ.sub.1J.sub.2, N.sub.3, COOJ.sub.1, CN, O--C(.dbd.O)--NJ.sub.1J.sub.2, N(H)C(.dbd.NH)NR.sub.1R.sub.2 or N(H)C(.dbd.X)N(H)J.sub.2 wherein X is O or S; each J.sub.1 and J.sub.2 is, independently, H, C.sub.1-C.sub.6 alkyl, substituted C.sub.1-C.sub.6 alkyl, C.sub.2-C.sub.6 alkenyl, substituted C.sub.2-C.sub.6 alkenyl, C.sub.2-C.sub.6 alkynyl, substituted C.sub.2-C.sub.6 alkynyl, C.sub.1-C.sub.6 aminoalkyl, substituted C.sub.1-C.sub.6 aminoalkyl or a protecting group; said oligomeric compound comprising at least one monomeric subunit that is other than a monomer having formula I, selected from a .beta.-D-ribonucleoside, a .beta.-D-2'-deoxyribonucleoside and a modified nucleoside wherein said modified nucleoside comprises at least a sugar substituent group, a 4'-S group or a bicyclic modified sugar; and wherein said oligomeric compound comprises from 8 to 40 nucleosides and/or modified nucleosides or mimetics in length. 23. The oligomeric compound of claim 22 wherein each of said modified nucleosides comprises at least a 2'-F modified sugar moiety, a 2'-OCH.sub.3 modified sugar moiety, a 2'-O--(CH.sub.2).sub.2--OCH.sub.3 modified sugar moiety, a 2'-O--CH.sub.2-4' bicyclic modified sugar moiety or a 4'-S modified sugar moiety. 24. The oligomeric compound of claim 22 wherein each Z is a substituted C.sub.1-C.sub.6 alkyl. 25. The oligomeric compound of claim 24 wherein each Z is substituted methyl. 26. The compound of claim 25 wherein each of said substituent groups is, independently, F, NJ.sub.1J.sub.2, N.sub.3, CN, OJ.sub.1, SJ.sub.1, O--C(.dbd.O)NJ.sub.1J.sub.2, N(H)C(.dbd.NH)NJ.sub.1J.sub.2 or N(H)C(.dbd.O)N(H)J.sub.2. 27. The oligomeric compound of claim 26 wherein each J.sub.1 and J.sub.2 is, independently H or C.sub.1-C.sub.6 alkyl. 28. The oligomeric compound of claim 22 wherein each Z is methyl, ethyl or methoxymethyl. 29. The oligomeric compound of claim 28 wherein each Z is methyl. 30. The oligomeric compound of claim 22 wherein each Z is vinyl. 31. The oligomeric compound of claim 22 wherein each Z is substituted acyl. 32. The oligomeric compound of claim 31 wherein each Z is C(.dbd.O)NJ.sub.1J.sub.2. 33. The oligomeric compound of claim 22 wherein one T.sub.3 is H, a hydroxyl protecting group or a linked conjugate group. 34. The oligomeric compound of claim 22 wherein one T.sub.4 is H, a hydroxyl protecting group or a linked conjugate group. 35. The oligomeric compound of claim 22 wherein at least one T.sub.3 an internucleoside linking group attached to the oligomeric compound. 36. The oligomeric compound of claim 22 wherein at least one T.sub.4 an internucleoside linking group attached to the oligomeric compound. 37. The oligomeric compound of claim 22 wherein each monomer having formula I has the configuration: ##STR00036## 38. The oligomeric compound of claim 22 wherein each monomer having formula I has the configuration: ##STR00037## 39. The oligomeric compound of claim 22 wherein each internucleoside linking group is, independently, a phosphodiester or phosphorothioate internucleoside linking group. 40. The oligomeric compound of claim 22 wherein each internucleoside linking group is a phosphorothioate internucleoside linking group. 